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To the Editor: Europe is 
progressively  becoming free of syl-
vatic rabies. However, reintroduction 
remains a threat. We report the 
incidence of rabies importation 
into the European Union (EU) and 
Switzerland and highlight common 
pathways for rabies introduction.
Rabies is a notifi able disease 
within the EU. Through comprehensive 
oral vaccination campaigns most 
EU member states have eliminated 
the disease. Despite this success, the 
danger of reintroduction of the disease 
is ever present. Rabies could be 
reintroduced through direct reentry of 
infected animals across land borders, 
as has happened in eastern Italy with 
an outbreak of fox rabies originating 
from the western Balkan region (1). 
Alternatively, reintroduction can occur 
through illegal or accidental import of 
an infected animal.
In an attempt to mitigate direct 
reentry, vaccination campaigns and 
technical assistance in nonmember 
states and in the EU have attempted 
to reduce the incidence of disease 
throughout the continent. Avoidance 
of importation of infected companion 
animals is achieved through 
enforcement of legislation. EU 
regulation No. 998/2003 defi nes the 
requirements that dogs or cats must 
meet before entry into the EU with 
the aim of preventing an infected but 
asymptomatic dog or cat from entering 
a member state from another country. 
Entry requirements include that the 
animal is identifi able by a microchip 
or tattoo, has been vaccinated 
against rabies, and, depending on 
the status of the country of origin 
according to Annex II of regulation 
No. 998/2003, has been serologically 
tested. A veterinary certifi cate should 
accompany the animal during the 
period of travel. Failure to meet 
these requirements could lead to the 
animal being returned to its country 
of origin, isolation of the animal 
until it meets the requirements, or, as 
a last resort if the fi rst 2 options are 
not feasible, euthanasia of the animal. 
Certain member states also stipulate 
application of antiparasite treatments 
before entry.
Despite these regulations, impor-
tation of animals incubating rabies can 
still occur through failure of border 
controls, ignorance of importation 
rules, or active subversion of these 
rules. The online Technical Appendix 
(www.cdc.gov/EID/content/17/4/753-
Techapp.pdf) lists documented cases 
during 2001–2010 of rabid dogs 
brought into the EU. Control measures 
in the form of euthanizing animals and 
contact investigation have ensured that 
the disease did not become established 
in a carnivore reservoir and no human 
incidence of disease resulted. Vigilance 
at the level of veterinary practitioners 
has also enabled quick discovery of 
suspected animal cases, which limited 
the number of secondary animal cases 
(online Technical Appendix). However, 
these discoveries point to a persistent 
trend of illegal animal movement into 
the EU.
Ignorance on the part of tourists 
of the danger of importing infectious 
disease and the rules governing 
animal movement underpin most 
of the cases. Juvenile dogs feature 
in many of the reports, presumably 
because puppies are attractive to 
tourists and, being small, are easily 
moved (2,3). A recurring pathway is 
that of vacationers visiting Morocco 
and returning to France through the 
Iberian Peninsula. This pathway has 
been confi rmed in 4 cases and is 
suspected in several other instances 
(online Technical Appendix; 4). In 
addition, rabies in dogs has been 
reported in the Spanish enclaves of 
Ceuta and Melilla on the north coast 
of Africa in recent years (5). A further 
route of introduction appears to be 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 4, April 2011 753
LETTERS
from western Balkan countries into 
Germany (6).
The costs associated with 
such introductions are numerous. 
These costs include the diagnostic 
investigation of suspected cases, 
particularly if molecular analysis 
is required to confi rm the source of 
the incursion, as was required when 
rabies was detected in a puppy in 
Switzerland (7).
Subsequent investigations to 
identify animal and human contact 
cases, often requiring >1 national 
or international agency, are needed 
to ensure that the disease has not 
spread and potential human contacts 
receive appropriate postexposure 
prophylaxis. In some cases the 
implementation of hotlines and 
several press releases was necessary to 
cope with the demand for information 
by the public (4). However, although 
media attention in such cases reached 
its primary and immediate objective, 
i.e., no secondary human rabies 
cases were reported, it may also have 
contributed to enhancing the sense 
of rabies risk, thereby prompting 
persons to associate dog bites in 
general with rabies and thus leading 
to increased numbers of persons 
seeking postexposure prophylaxis 
unnecessarily for several months (8). 
Further costs are also incurred in the 
euthanasia or quarantine of contact 
animals.
The evidence suggests that this 
trend for importation of animals 
incubating rabies will continue, 
requiring member states to maintain 
vigilance with measures appropriate 
to the potential risk and consequences 
of a rabies outbreak. This vigilance 
should involve rapid investigation 
of suspected cases of disease, 
maintenance of rabies diagnostic 
capacity and contingency plans, 
and improved coordination between 
member states to deal with disease 
introduction.
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To the Editor: Tocilizumab 
is a monoclonal antibody that 
competitively inhibits binding of 
interleukin-6 (IL-6) to its receptor. It is 
approved for treatment of rheumatoid 
arthritis (RA) as monotherapy or 
with methotrexate. We report a case 
of cytomegalovirus (CMV) disease 
complicating treatment with an IL-6 
receptor antagonist.
A 41-year-old man who had 
a diagnosis of nonerosive RA 
(seronegative for rheumatoid factor 
and anticyclic citrillinated peptide 
antibody) in 1994 had fevers in May 
2010. Previous treatment included 
etanercept, methotrexate, and various 
doses of prednisone (highest dose 40 
mg/day). Because of uncontrolled RA, 
he was treated with monthly infusions 
of tocilizumab, 600 mg (≈4 mg/kg, 
fi rst infusion in March 2010 and the 
second in April 2010), methotrexate 
(7.5 mg/week), and prednisone (5 mg/
day from April 2010 onwards).
Fever, a productive cough 
with white sputum, and wheezing 
developed ≈3 weeks after his second 
infusion of tocilizumab, which 
resulted in RA symptom resolution 
(Figure). Tapering of steroid treatment 
and levofl oxacin resulted in some 
improvement. However, after 1 week, 
persistent fever led to hospitalization. 
Worsening shortness of breath, nausea, 
and vomiting developed. Results of 
computed tomography (CT) scans of 
the chest, abdomen, and pelvis were 
unremarkable. He was transferred 
to the Cleveland Clinic because of 
hypotension and intravenous dye–
induced renal failure.
Daily fever (<103°F), shortness 
of breath, nausea, and mild diarrhea 
persisted. After cultures were 
obtained, he received 1 g vancomycin, 
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